CCR5 and familial pancreatic carcinoma: With regard to CCL5’s pro-tumorigenic functions on PDAC epithelial cells, Singh et al. identified the increased expression of CCL5/CCR5 in metastatic pancreatic cancer tissues, via immunohistochemistry (IHC), as compared to the non-neoplastic kind [62].